NASDAQ
Evofem Biosciences, Inc. (EVFM) has a revenue compound annual growth rate of 114.35% over 5 years and 70.02% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.